
DIVINE's table on treatments previous to hospital admission
Source:R/concomitant_medication.R
concomitant_medication.RdInformation on previous treatments for patients included in the DIVINE cohort. Data was collected at hospital admission.
Usage
data(concomitant_medication)Format
A data frame with 5813 rows and 11 columns
- record_id:
Identifier of each record. This information does not match the real data.
- covid_wave:
A factor with levels
Wave 1,Wave 2,Wave 3, andWave 5. COVID-19 wave.- center:
A factor with levels
Hospital A,Hospital B,Hospital C,Hospital D, andHospital E. Center of admission- statins_pre:
A factor with levels
NoandYes. Previous treatment with statins- cortis_pre:
A factor with levels
NoandYes. Previous treatment with corticosteroids- acei_pre:
A factor with levels
NoandYes. Previous treatment with angiotensin-converting enzyme (ACE) inhibitors- ara2_pre:
A factor with levels
NoandYes. Previous treatment with angiotensin II receptor antagonists (ARA-II)- cortis_systemic_pre:
A factor with levels
NoandYes. Routine treatment with systemic corticosteroids- cortis_inhaled_pre:
A factor with levels
NoandYes. Routine treatment with inhaled corticosteroids- anticoagulants_pre:
A factor with levels
NoandYes. Previous treatment with anticoagulants- immunosuppre_pre:
A factor with levels
NoandYes. Previous treatment with immunosuppressants
References
Pallarès, N., Tebé, C., Abelenda-Alonso, G., Rombauts, A., Oriol, I., Simonetti, A. F., Rodríguez-Molinero, A., Izquierdo, E., Díaz-Brito, V., Molist, G., Gómez Melis, G., Carratalà, J., Videla, S., & MetroSud and Divine study groups (2023). Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study. Infectious diseases and therapy, 12(1), 273–289. https://doi.org/10.1007/s40121-022-00705-w